This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PAROTIDGLAND_EXALLC for full statistics.
Malignant neoplasm of parotid gland
C3_PAROTIDGLAND
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
269 |
4. Check minimum number of eventsNone |
269 |
5. Include endpointsNone |
269 |
6. Filter based on genotype QC (FinnGen only) |
269 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of parotid gland
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 269 | 127 | 142 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 61.36 | 57.98 | 64.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 249
- Matched controls
- 2490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
169.9
143
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
248.9
163.6
154
16
ELB50
NOMESCO Finland
Total parotidectomy
1545.0
106.5
96
*
ELB40
NOMESCO Finland
Partial parotidectomy
271.8
103.1
99
6
EP1AE
NOMESCO Finland
Neck ultrasound examination
18.5
49.7
80
62
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
140.3
44.4
46
*
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
+∞
43.0
40
*
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
+∞
40.8
38
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
158.0
39.0
40
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
17.7
36.2
58
42
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
29.8
28
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
17.8
29.7
47
32
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
44.9
28.9
35
9
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
25.4
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
23.3
113
402
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
22.2
21
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
27.1
21.4
29
12
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
+∞
21.1
20
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
120.1
20.9
22
*
G51.0
ICD-10 Finland
Bell palsy
21.1
20.5
30
16
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
+∞
20.1
19
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
44.1
19.9
24
6
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
57.0
18.3
21
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
193.2
17.8
18
*
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
16.9
16
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
+∞
16.9
16
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.2
16.3
116
529
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
90.9
15.8
17
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
32.2
14.1
18
6
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
36.3
13.7
17
5
130
Kela drug reimbursment
Malignant tumour
4.6
13.6
50
129
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
13.0
83
338
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.1
12.7
35
65
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
28.3
12.2
16
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.6
12.1
21
18
8562/3-C07.9
ICD-O-3
Epithelial-myoepithelial carcinoma of parotid gland
+∞
11.5
11
*
8140/3-C07.9
ICD-O-3
Adenocarcinoma, NOS, of parotid gland
+∞
11.5
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.7
11.5
108
554
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
45.5
11.0
13
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
9.2
10.8
22
26
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
10.5
10
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
+∞
10.5
10
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
10.4
49
157
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.1
10.3
28
51
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
10.1
31
66
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
17.6
10.0
15
9
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
7.1
9.7
23
35
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.7
9.7
24
39
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
+∞
9.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
8010/3-C07.9
ICD-O-3
Carcinoma, NOS, of parotid gland
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
8.3
9.3
20
26
UDC00
NOMESCO Finland
Ear microscopy
4.4
9.3
34
87
WF002
NOMESCO Finland
Radical radiotherapy
4.9
9.0
29
65
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
9.0
53
198
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.5
8.9
43
141
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
51.9
8.7
10
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
12.2
8.7
15
13
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
10.6
8.7
16
16
ED1AA
NOMESCO Finland
Mandipular X-ray examination
28.6
8.6
11
*
H02.2
ICD-10 Finland
Lagophthalmos
28.6
8.6
11
*
4405
FHL
Partial removal of the parotid gland
93.1
8.5
9
*
8941/3-C07.9
ICD-O-3
Carcinoma ex pleomorphic adenoma of parotid gland
+∞
8.4
8
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
8.4
8
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.4
8.3
42
142
WX110
NOMESCO Finland
Local anesthesy
2.3
8.3
173
1252
S04
ICPC
Lump/swelling localized
3.6
8.3
37
114
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
8.2
112
669
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
17.9
8.2
12
7
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
17.9
8.2
12
7
R4190
NOMESCO Finland
Nutritional therapy
5.8
8.1
22
41
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.5
8.0
20
33
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.9
7.9
16
19
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
11.3
7.9
14
13
WX402
NOMESCO Finland
General anaesthesia
2.8
7.9
54
222
C82.1
ICD-10 Finland
Follicular lymphoma grade II
46.5
7.8
9
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
+∞
7.3
7
*
8502/3-C07.9
ICD-O-3
Secretory carcinoma of parotid gland
+∞
7.3
7
*
8147/3-C07.9
ICD-O-3
Basal cell adenocarcinoma of parotid gland
+∞
7.3
7
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
16.4
7.3
11
7
K05.30
ICD-10 Finland
Periodontitis complex
3.0
7.2
42
157
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
31.0
7.2
9
*
EBA10
NOMESCO Finland
Surgical removal of tooth
3.3
7.1
36
122
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
6.9
105
645
A07AA02
ATC
nystatin; oral
3.5
6.8
31
97
K11.2
ICD-10 Finland
Sialoadenitis
7.5
6.8
15
21
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.4
6.7
23
56
XW000
NOMESCO Finland
Bone marrow biopsy
4.5
6.6
22
52
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
10.4
6.6
12
12
4404
FHL
Complete removal of the parotid gland
71.6
6.5
7
*
ELB60
NOMESCO Finland
Radical parotidectomy sacrificing the facial nerve
71.6
6.5
7
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
71.6
6.5
7
*
UJC01
NOMESCO Finland
Scopy of lower throat
14.8
6.4
10
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.4
118
777
EMB10
NOMESCO Finland
Tonsillectomy
5.3
6.3
18
36
S18
ICPC
Laceration/cut
2.0
6.3
111
715
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
6.3
6
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
10.4
6.1
11
11
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.5
6.1
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
80
45
24.88
103.32
1.4
1.3
—
—
—
0
0
(4035726)
105
203
7.84
57.03
1.7
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
19
10.68
16.89
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
153
852
2.85
15.82
3.0
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
65
271
2.84
11.11
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
59
246
2.79
10.01
2.4
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
178
1227
2.33
9.73
12.5
9.4
e9/l
3.8
4.1
1.48
162
1072
(3001604) Monocytes [#/volume] in Blood
156
1040
2.19
8.96
6.0
5.5
e9/l
0.5
0.6
1.48
138
894
(3013115) Eosinophils [#/volume] in Blood
158
1067
2.17
8.68
6.5
5.8
e9/l
0.2
0.2
2.76
144
941
(3006504) Eosinophils/100 leukocytes in Blood
148
976
2.15
8.63
6.4
5.7
%
2.8
2.9
0.20
139
915
(3018010) Neutrophils/100 leukocytes in Blood
149
986
2.15
8.60
6.5
5.6
%
59.3
57.5
0.98
137
931
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
50
207
2.74
8.53
1.9
2.4
g/l
0.2
0.2
2.48
50
192
(40768795) Lymph node Pathology biopsy report
13
19
7.14
8.52
1.4
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
155
1044
2.14
8.51
6.1
5.6
e9/l
0.0
0.0
0.42
138
901
(3019198) Lymphocytes [#/volume] in Blood
157
1063
2.15
8.50
6.2
5.6
e9/l
1.6
1.9
1.27
142
938
(3019069) Monocytes/100 leukocytes in Blood
148
980
2.13
8.49
6.7
6.0
%
8.9
8.7
0.26
138
927
(3002030) Lymphocytes/100 leukocytes in Blood
150
1002
2.12
8.37
6.6
5.8
%
25.4
27.2
1.06
137
939
(42870588) Differential panel, method unspecified - Blood
114
699
2.09
7.85
6.6
5.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
146
982
2.06
7.81
6.5
5.7
mmol/l
1.2
1.2
1.04
134
890
(3022096) Basophils/100 leukocytes in Blood
142
946
2.06
7.79
6.5
5.7
%
0.6
0.7
0.05
133
890
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
54
249
2.46
7.36
5.6
4.3
u/l
230.8
237.4
0.24
54
240
(3015377) Calcium [Moles/volume] in Serum or Plasma
116
741
1.99
6.94
6.1
3.3
mmol/l
2.3
2.3
0.06
108
652
(40758558) Short blood count panel - Blood
89
528
2.02
6.47
10.8
7.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
523
2.01
6.35
2.5
2.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
150
1082
1.87
5.94
7.5
6.6
mmol/l
1.2
1.2
0.28
129
911
(3033658) Prothrombin time (PT) actual/Normal
88
548
1.90
5.42
4.0
3.7
%
87.4
88.9
0.18
88
537
(3044640) Blood type and Crossmatch panel - Blood
103
685
1.82
5.10
2.5
2.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
204
1674
1.90
4.87
10.1
7.7
u/l
81.4
80.5
0.07
192
1554
(3024561) Albumin [Mass/volume] in Serum or Plasma
131
953
1.73
4.65
6.1
4.5
g/l
35.5
35.2
0.24
117
899
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
136
1002
1.72
4.60
3.8
4.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
24
4.29
3.92
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
128
2.33
3.86
2.1
2.8
e9/l
4.0
3.7
0.25
18
98
(3018418) pH of Serum or Plasma
95
659
1.68
3.85
6.2
4.0
ph
7.4
7.4
0.21
15
126
(3042936) Bacteria identified in Isolate by Culture
53
318
1.83
3.54
2.0
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
130
2.20
3.31
1.1
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
82
571
1.63
3.19
2.4
2.8
umol/l
337.1
6451.2
2.22
70
493
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
94
2.34
3.05
1.2
1.9
g/l
2.7
3.1
1.16
16
73
(3008295) Osmolality of Serum or Plasma
9
22
4.19
2.91
1.3
1.1
mosm/kgh2o
294.9
277.4
—
9
16
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
27
140
2.03
2.77
6.5
8.2
%
0.6
0.7
0.30
27
140
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
49
2.74
2.66
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
15
4.76
2.61
1.9
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
101
2.17
2.61
1.2
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
101
2.17
2.61
1.2
1.9
g/l
3.2
3.8
1.73
15
71
(40768806) Pleura Pathology biopsy report
9
26
3.54
2.50
1.6
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
239
2193
1.81
2.44
20.9
17.9
mmol/l
3.9
4.0
2.26
234
2133
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
8
6.34
2.38
7.8
5.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
238
2186
1.77
2.36
20.4
17.8
mmol/l
139.4
139.7
0.64
233
2126
(3004588) Protein electrophoresis panel - Serum or Plasma
29
165
1.85
2.30
1.3
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
29
3.17
2.24
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
43
2.62
2.12
2.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
40
590
0.62
2.06
4.1
3.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
25
142
1.84
2.01
6.6
7.9
%
1.4
1.4
0.01
25
142
(3009542) Hematocrit [Volume Fraction] of Blood
205
1847
1.46
1.89
21.3
16.2
%
38.2
39.7
1.33
142
1297
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
17
3.58
1.85
1.3
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
17
3.58
1.85
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
229
2114
1.56
1.83
19.6
15.2
mg/l
24.2
24.2
0.00
190
1690
(3019225) pH of Specimen
34
218
1.64
1.82
3.1
4.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
23
3.10
1.81
1.1
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
105
851
1.38
1.79
2.4
2.3
nmol/l
84.0
77.0
1.33
94
753
(3045414) Leukocytes [Presence] in Urine
16
81
2.04
1.78
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
41
2.49
1.77
2.0
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
179
1583
1.39
1.77
4.6
4.2
mm/h
13.3
12.6
0.22
159
1450
(3014576) Chloride [Moles/volume] in Serum or Plasma
42
286
1.56
1.76
5.6
6.4
mmol/l
104.5
103.8
0.38
42
279
(3045788) Cell count panel - Pleural fluid
6
18
3.38
1.75
1.5
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
39
263
1.56
1.71
1.7
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
37
247
1.58
1.69
1.3
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
76
2.03
1.68
1.6
3.7
—
3.0
—
0
8
(3020564) Creatinine [Moles/volume] in Serum or Plasma
238
2228
1.59
1.65
22.2
18.2
umol/l
80.5
80.0
0.09
238
2228
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
14
3.62
1.62
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
73
565
1.40
1.62
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
53
704
0.69
1.61
3.0
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
238
2231
1.58
1.61
12.6
10.9
u/l
25.8
26.1
0.06
225
2147
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
209
1.60
1.60
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
37
251
1.55
1.58
5.2
7.0
mmol/l
1.1
1.1
0.00
29
203
(3032080) INR in Blood by Coagulation assay
111
922
1.35
1.58
7.2
8.5
inr
1.3
1.3
0.20
32
269
(3000991) Gas panel - Venous blood
29
188
1.61
1.50
6.5
7.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
37
2.48
1.49
1.4
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
39
2.35
1.44
1.4
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
65
820
0.73
1.43
4.0
3.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
17
2.98
1.36
2.0
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
112
948
1.31
1.36
11.2
10.1
e9/l
0.0
0.0
0.53
93
778
(40760888) Immunoglobulin light chains.free panel - Serum
11
54
2.08
1.34
1.3
4.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
36
253
1.49
1.33
2.5
2.9
umol/l
7.1
8.6
0.31
36
221
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
18
2.81
1.29
1.2
1.2
u/l
151.4
297.8
—
5
18
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
63
1.95
1.25
1.7
2.4
u/ml
0.4
0.3
—
5
38
(3044889) 12 lead EKG panel
168
1513
1.29
1.24
3.9
4.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
37
2.20
1.22
1.4
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.34
1.19
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
34
0.00
1.16
0.0
1.1
—
8.0
—
0
18
(3013826) Glucose [Moles/volume] in Serum or Plasma
146
1303
1.26
1.11
4.8
4.4
mmol/l
6.6
6.8
0.64
139
1222
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
41
1.98
1.09
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
121
0.48
1.08
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
213
1995
1.33
1.08
18.9
14.5
ml/min/173m2
78.7
77.9
0.27
192
1638
(3021960) Folate [Moles/volume] in Serum or Plasma
66
536
1.31
1.06
1.7
1.6
nmol/l
19.4
20.9
0.29
52
452
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
257
1.42
1.06
6.0
8.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
22
2.30
1.04
1.8
1.9
pg
33.2
32.2
—
5
22
(3023520) Reticulocytes [#/volume] in Blood
28
198
1.46
1.03
2.6
2.7
e9/l
72.2
70.0
0.07
16
157
(3002173) Hemoglobin [Mass/volume] in Arterial blood
29
208
1.44
0.99
5.8
7.8
g/l
120.4
119.6
0.08
29
201
(3020891) Body temperature
15
92
1.67
0.99
3.1
4.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
166
1.49
0.98
3.5
2.9
ml/min/173m2
50.7
61.8
—
9
71
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
169
1547
1.25
0.98
4.3
3.9
pmol/l
14.7
14.9
0.44
152
1382
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
62
1.81
0.95
1.3
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
51
1.79
0.95
2.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
19
126
1.55
0.94
1.5
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
241
2312
1.41
0.93
27.9
22.3
e9/l
244.6
244.9
0.03
234
2249
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
537
1.28
0.92
2.0
2.0
mg/l
2.7
3.1
0.93
47
460
(3003327) Ova and parasites identified in Stool by Light microscopy
11
63
1.78
0.91
1.6
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
39
300
1.35
0.91
1.3
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
241
2314
1.40
0.90
27.9
22.2
e12/l
4.4
4.5
0.75
233
2243
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
29
2.09
0.90
1.0
3.2
—
31.7
—
0
10
(3010813) Leukocytes [#/volume] in Blood
241
2315
1.39
0.89
27.9
22.3
e9/l
6.5
6.7
0.81
233
2243
(4010399)
22
154
1.47
0.86
1.4
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
203
1910
1.26
0.85
5.1
4.7
mu/l
2.0
2.6
0.43
178
1721
(3004789) Transferrin [Mass/volume] in Serum or Plasma
42
331
1.32
0.84
3.0
2.2
g/l
2.2
2.3
0.78
37
305
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
100
878
1.22
0.82
2.4
2.0
pmol/l
97.2
95.6
0.12
51
454
(3027945) Reticulocytes/100 erythrocytes in Blood
34
261
1.35
0.81
2.3
2.7
%
1.8
1.8
0.14
28
241
(1002224) Polysomnography panel
5
96
0.51
0.79
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
472
1.26
0.79
2.9
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
82
1.62
0.79
1.7
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
48
1.69
0.79
4.6
2.4
—
—
—
0
0
(4281824)
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
37
291
1.31
0.76
22.2
22.5
inr
1.5
1.3
—
6
40
(40761511) CBC panel - Blood by Automated count
228
2184
1.29
0.76
15.6
14.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
83
721
1.22
0.75
2.6
3.1
ng/l
1260.0
1488.8
0.34
69
612
(3019309) Folate [Moles/volume] in Red Blood Cells
53
438
1.26
0.75
1.9
1.7
nmol/l
1039.7
1226.4
0.61
38
335
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
24
2.10
0.75
2.2
1.2
nmol/l
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
25
2.02
0.73
1.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
350
0.75
0.71
1.2
1.3
iu/ml
13.8
34.7
—
8
117
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
2.4
1.2
—
—
—
0
0
(4094501)
9
59
1.54
0.69
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
28
1.80
0.66
1.4
2.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
2.4
1.2
nmol/l
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
94
1048
0.84
0.66
5.0
5.1
estimate
0.0
0.0
0.00
14
204
(3022145) Colonoscopy Study observation
20
267
0.73
0.64
1.1
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
71
618
1.20
0.63
4.5
4.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
49
1.65
0.62
1.8
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
330
0.77
0.60
1.2
1.3
u/ml
24.1
9.6
—
9
130
(3044242) Glucose [Moles/volume] in Arterial blood
0
20
0.00
0.60
0.0
4.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
96
1061
0.85
0.59
3.6
3.8
estimate
0.0
0.0
0.00
14
191
(3052851) Hemolysis interference index of Serum or Plasma
10
64
1.58
0.59
4.5
3.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
99
897
1.16
0.55
3.4
3.9
ng/l
34.3
43.2
0.39
67
667
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
108
1.41
0.54
6.0
8.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
125
1155
1.15
0.53
2.4
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
75
1.49
0.51
2.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
106
0.65
0.49
1.6
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
237
1.25
0.48
4.4
3.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
111
1.37
0.48
2.5
3.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
656
0.85
0.47
3.6
4.5
%
25.3
21.5
1.02
29
319
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.2
1.1
—
3.4
—
0
11
(3045424) Erythrocytes [Presence] in Urine
5
32
1.57
0.42
1.4
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
55
486
1.17
0.42
1.8
1.7
mg/l
1.9
1.4
0.32
43
383
(3037756) Immunofixation for Serum or Plasma
8
58
1.39
0.42
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
11
79
1.41
0.41
2.5
3.2
g/l
2.4
0.2
—
6
26
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
16
0.00
0.41
0.0
5.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.0
—
25571.6
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
34.4
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
486.9
—
0
11
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
265.0
—
0
10
(3043409) Potassium [Moles/volume] in Arterial blood
10
71
1.42
0.40
3.5
3.6
mmol/l
3.8
3.9
—
10
66
(3037467) Urinalysis macro (dipstick) panel - Urine
152
1443
1.12
0.39
4.8
4.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
35
1.44
0.39
2.4
2.1
%
72.0
58.2
—
5
35
(3001122) Ferritin [Mass/volume] in Serum or Plasma
95
878
1.13
0.39
3.3
2.6
ug/l
174.9
133.9
0.39
78
806
(3029937) Albumin [Presence] in Urine by Test strip
50
561
0.87
0.37
3.7
4.0
estimate
0.0
0.0
0.00
15
201
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
117
1.30
0.36
1.7
2.5
%
1.3
1.3
0.03
15
117
(3019832) Treponema pallidum Ab [Presence] in Serum
9
124
0.72
0.36
1.3
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
313
1.17
0.34
3.3
2.2
%
24.1
22.6
0.26
30
277
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
74
1.36
0.33
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
21
174
1.22
0.32
2.8
2.2
g/l
11.1
10.2
0.31
21
159
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
277
1.18
0.32
4.2
4.9
%
34.9
32.0
0.72
20
180
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
165
1.23
0.32
2.4
3.2
—
—
—
0
0
(3013512) EKG study
73
672
1.12
0.32
4.3
4.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
54
1.30
0.30
1.1
1.1
—
14.9
—
0
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
356
1.15
0.29
2.3
3.0
e6/l
1.9
2.2
0.09
22
188
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
214
1.19
0.29
1.8
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
143
1370
1.09
0.28
2.7
3.3
u/l
45.6
51.7
0.38
133
1285
(3025941) Bacteria identified in Stool by Culture
9
118
0.75
0.28
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
66
1.22
0.27
1.3
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
378
1.13
0.27
2.4
2.7
e6/l
1.1
1.0
0.04
25
207
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
787
1.10
0.26
2.7
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
71
0.70
0.26
4.2
4.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
453
0.89
0.25
1.6
1.8
pmol/l
434.7
448.3
0.13
29
375
(3048689) Calprotectin [Mass/mass] in Stool
21
244
0.85
0.25
1.6
2.1
ug/g
80.3
140.0
1.25
14
194
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
148
0.80
0.25
1.5
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
67
719
0.91
0.25
3.9
2.5
u/l
60.5
55.7
0.13
60
666
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
256
1.15
0.24
3.8
4.3
ug/l
6.1
50.4
0.82
23
215
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
482
0.90
0.24
2.7
3.0
ug/l
0.7
0.7
0.04
29
312
(36660697) Celiac disease serology panel - Serum
12
147
0.81
0.24
1.1
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
64
595
1.10
0.24
3.1
3.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
38
1.32
0.23
3.0
6.1
—
144.2
—
0
6
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
353
1.12
0.23
1.9
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
21
182
1.17
0.22
1.8
2.8
kpa
4.6
4.2
0.45
21
173
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
102
0.78
0.21
1.1
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
103
0.77
0.21
1.5
2.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.5
—
0.1
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.0
—
8.5
—
0
10
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
210
2058
1.09
0.21
4.4
4.8
mmol/l
5.9
6.1
0.95
183
1876
(4027681)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
17
145
1.18
0.21
1.7
1.6
g/l
1.9
1.4
0.24
17
131
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
78
824
0.92
0.20
4.9
5.1
ug/l
2.2
2.7
0.46
66
733
(3035350) Ketones [Presence] in Urine by Test strip
99
1036
0.93
0.20
3.3
3.7
estimate
0.0
0.0
0.00
15
207
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
8.3
—
0
6
(3011648) Oxygen content in Venous blood
0
14
0.00
0.20
0.0
1.9
—
12.0
—
0
14
(40768443) Skin Pathology biopsy report
12
99
1.22
0.20
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
202
1979
1.08
0.19
3.8
4.2
mmol/l
1.2
1.3
1.80
171
1810
(40761536) Microorganisms panel - Urine sediment
16
185
0.86
0.19
5.5
3.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
60
563
1.08
0.18
1.5
1.7
mmol/l
1.1
1.4
1.92
50
463
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
253
1.12
0.17
1.6
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.6
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
339
0.90
0.17
3.1
1.8
s
31.8
29.6
1.06
31
330
(3036489) Thrombin time
5
70
0.71
0.17
2.8
1.9
s
21.4
21.1
—
5
63
(4034850)
8
70
1.15
0.16
6.0
11.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
70
1.15
0.16
1.9
1.2
—
5.3
—
0
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
73
1.10
0.16
1.9
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
161
0.86
0.15
1.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
140
1.15
0.15
3.3
3.3
mmol/l
1.1
1.5
—
10
102
(3012516) Albumin [Mass/volume] in Urine
62
652
0.94
0.14
3.4
3.2
mg/l
94.5
152.0
0.23
44
427
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
107
0.84
0.13
2.6
2.4
—
—
—
0
0
(3000492) Spirometry study
21
190
1.11
0.13
2.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
133
1.14
0.12
4.1
2.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
13
147
0.88
0.11
2.6
2.4
—
12.3
—
0
7
(40768797) Stomach Pathology biopsy report
32
299
1.08
0.11
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
44
419
1.06
0.09
1.3
1.4
g/l
2.1
2.5
1.14
27
247
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
46
1.09
0.09
1.2
1.1
u/l
28.5
15.8
—
5
37
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
126
1.12
0.09
1.6
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
68
658
1.04
0.08
3.4
3.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
63
0.79
0.08
1.8
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
64
0.78
0.08
1.6
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
68
1.03
0.08
1.4
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
75
0.80
0.07
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
75
0.80
0.07
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
75
0.80
0.07
1.5
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
142
0.91
0.06
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
100
0.90
0.06
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
64
623
1.04
0.06
3.0
3.2
e6/l
0.4
0.6
0.43
51
462
(3020682) Albumin/Creatinine [Ratio] in Urine
67
687
0.97
0.06
4.3
4.1
mg/mmol
16.3
9.8
0.32
45
435
(3019060) Gas panel - Arterial blood
14
151
0.92
0.05
2.8
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
110
1.10
0.05
3.5
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
206
2046
1.03
0.04
4.2
4.6
mmol/l
1.5
1.5
0.02
179
1875
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
428
1.03
0.04
4.1
3.6
ng/l
55.5
217.2
1.34
39
342
(3021447) Carbon dioxide [Partial pressure] in Venous blood
22
211
1.05
0.03
3.0
3.6
kpa
5.8
5.7
0.00
22
204
(3012544) pH of Venous blood
21
218
0.96
0.02
3.0
3.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
207
2061
1.02
0.02
4.3
4.7
mmol/l
4.6
4.6
0.04
185
1897
(3037522) Nuclear Ab [Titer] in Serum
30
292
1.03
0.02
1.2
1.3
titre
1110.0
526.5
—
8
68
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
210
2108
0.98
0.01
4.7
5.2
mmol/l
2.6
2.7
0.41
182
1926
(3002582) Erythrocytes [#/volume] in Urine
69
683
1.01
0.01
2.9
3.3
e6/l
34.9
144.6
0.60
52
529
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
136
0.95
0.00
1.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
156
0.96
0.00
1.8
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
446
0.98
0.00
1.1
1.2
u/ml
8.2
1.5
—
7
110
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
262
0.99
0.00
1.6
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
10
99
1.01
0.00
1.6
1.8
ug/l
1.2
3.9
—
10
88
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
291
1.00
0.00
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
253
0.99
0.00
1.7
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
143
0.98
0.00
1.8
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
46
455
1.01
0.00
4.6
4.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
10
104
0.96
0.00
4.8
3.9
mmol/l
23.7
23.9
—
10
95
(3008152) Bicarbonate [Moles/volume] in Arterial blood
14
136
1.03
0.00
4.9
7.1
mmol/l
25.5
24.5
1.04
14
130
(3000850) Epithelial cells [#/volume] in Urine
48
476
1.01
0.00
2.5
2.7
e6/l
6.1
4.8
0.28
43
416
(3018095) Leukocytes [#/volume] in Urine
78
785
0.99
0.00
3.6
3.9
e6/l
65.0
77.5
0.13
57
558
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
198
1975
1.01
0.00
5.6
6.3
mmol/mol
39.1
40.7
2.07
174
1839
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
1.8
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.2
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
9.8
—
0
8
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.4
3.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
38.7
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.2
—
0.7
—
0
6
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
96
0.94
0.00
1.2
1.2
u/ml
37.7
164.8
—
9
88
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
18.9
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
5.5
—
26.6
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
7.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
67
670
1.00
0.00
3.4
3.1
mmol/l
7.4
7.6
0.14
48
554
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.2
—
110.8
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
1.4
—
0
8
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(4198724)
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
-0.00
0.0
1.6
—
4.2
—
0
5
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
150.0
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PAROTIDGLAND – Malignant neoplasm of parotid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).